Get the Stockscreener App
9.41
0.84%
-0.08
After Hours:
9.74
0.33
+3.51%
Rxsight Inc stock is traded at $9.41, with a volume of 867.20K.
It is down -0.84% in the last 24 hours and up +6.81% over the past month.
RxSight Inc is a commercial-stage medical technology company dedicated towards improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The company operates and manages its business in one reportable segment, the research and development, manufacture and sale of light adjustable lenses and related capital equipment.
See More
Previous Close:
$9.49
Open:
$9.48
24h Volume:
867.20K
Relative Volume:
0.64
Market Cap:
$385.02M
Revenue:
$128.29M
Net Income/Loss:
$-30.69M
P/E Ratio:
-11.48
EPS:
-0.82
Net Cash Flow:
$-27.17M
1W Performance:
+1.07%
1M Performance:
+6.81%
6M Performance:
-62.13%
1Y Performance:
-82.43%
1-Day Range:
$9.15
$9.58
1-Week Range:
$8.835
$9.58
52-Week Range:
$6.32
$55.57
Rxsight Inc Stock (RXST) Company Profile
Name
Rxsight Inc
Sector
Industry
Phone
949-521-7822
Address
100 COLUMBIA STREET, ALISO VIEJO
Compare RXST with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RXST
Rxsight Inc
|
9.41 | 388.29M | 128.29M | -30.69M | -27.17M | -0.82 |
|
ABT
Abbott Laboratories
|
136.04 | 234.21B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
97.83 | 145.55B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
376.83 | 144.45B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
95.08 | 122.61B | 34.20B | 4.69B | 5.30B | 3.63 |
|
EW
Edwards Lifesciences Corp
|
74.41 | 43.77B | 5.69B | 1.41B | 577.90M | 6.95 |
Rxsight Inc Stock (RXST) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-15-25 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jul-10-25 | Downgrade | Jefferies | Buy → Hold |
| Jul-09-25 | Downgrade | BTIG Research | Buy → Neutral |
| Jul-09-25 | Downgrade | Oppenheimer | Outperform → Perform |
| Jul-09-25 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| May-19-25 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Apr-15-25 | Initiated | Piper Sandler | Neutral |
| Apr-09-25 | Downgrade | UBS | Buy → Neutral |
| Apr-04-25 | Downgrade | JP Morgan | Overweight → Underweight |
| Apr-03-25 | Downgrade | BofA Securities | Buy → Underperform |
| Dec-20-24 | Downgrade | Stifel | Buy → Hold |
| Dec-11-24 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Dec-06-24 | Initiated | UBS | Buy |
| Oct-29-24 | Initiated | Jefferies | Buy |
| Aug-20-24 | Reiterated | Needham | Buy |
| Aug-06-24 | Reiterated | Needham | Buy |
| May-07-24 | Reiterated | BTIG Research | Buy |
| Dec-13-23 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Dec-12-23 | Initiated | Stifel | Buy |
| Dec-04-23 | Initiated | Morgan Stanley | Overweight |
| Apr-13-23 | Initiated | Oppenheimer | Outperform |
| Dec-12-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Apr-08-22 | Initiated | Needham | Buy |
View All
Rxsight Inc Stock (RXST) Latest News
RxSight, Inc. Class Action: Levi & Korsinsky Reminds RxSight, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 22, 2025RXST - PR Newswire
RxSight, Inc. Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law Firm Before September 22, 2025 to Discuss Your RightsRXST - PR Newswire
RXST Deadline: RXST Investors with Losses in Excess of $100K Have Opportunity to Lead RxSight, Inc. Securities Fraud Lawsuit - Eastern Progress
INVESTOR CLASS ACTION: RxSight, Inc. Investors are Reminded of the Ongoing Securities Fraud Lawsuit after Stock Plummeted 38% -- Contact BFA Law - GlobeNewswire Inc.
RxSight (RXST) Fell Due to Missed Expectations and Guidance Reduction - MSN
Deadline Soon: RxSight, Inc. (RXST) Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit - The Globe and Mail
RXSIGHT DEADLINEALERT: Bragar Eagel & Squire, P.C. Reminds - GlobeNewswire
Deadline Alert: RxSight, Inc. (RXST) Investors Who Lost - GlobeNewswire
Levi & Korsinsky Urges RxSight, Inc. (RXST) Shareholders to Act Before Lead Plaintiff Deadline September 22, 2025 - Barchart.com
RXST DEADLINE: ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages RxSight, Inc. Investors to Secure Counsel Before Important September 22 Deadline in Securities Class ActionRXST - MarketScreener
Shareholders that lost money on RxSight, Inc. (RXST) should - GlobeNewswire
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of RxSight - Morningstar
RxSight, Inc. Investors: Please contact the Portnoy Law - GlobeNewswire
RXSIGHT INVESTORS: New RxSight, Inc. Securities Class - GlobeNewswire
EXTENDED CLASS PERIOD: Investor Files Class Action Lawsuit Against RxSight, Inc. and Attorneys Announce Opportunity for Investors with Substantial Losses to Lead Class Action Lawsuit - PR Newswire
RxSight, Inc. Investigated for Securities Fraud ViolationsContact the DJS Law Group to Discuss Your RightsRXST - MarketScreener
Goldman Sachs Group Inc. Buys 113,767 Shares of RxSight, Inc. $RXST - MarketBeat
Gainey McKenna & Egleston Announces A Class Action Lawsuit Has B - GuruFocus
EXPANDED CLASS PERIOD: Berger Montague Advises RxSight, Inc. (NASDAQ: RXST) Investors to Inquire About a Securities Fraud Class Action by September 22, 2025 - standard-journal.com
RxSight, Inc. (RXST) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - MarketScreener
Securities Lawsuit Alert: RxSight, Inc. (RXST)Contact Levi & Korsinsky Before September 22, 2025 - Barchart.com
RXST INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
Silicon Valley - FinancialContent
Millennium Management LLC Decreases Position in RxSight, Inc. $RXST - MarketBeat
Royal Bank of Canada Trims Holdings in RxSight, Inc. $RXST - MarketBeat
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of RxSight - Newsfile
Lost Money on RxSight, Inc. (RXST)? Join Class Action Suit Seeking Recovery – Contact Levi & Korsinsky - GlobeNewswire
EXTENDED CLASS PERIOD: Robbins Geller Rudman & Dowd LLP Files Class Action Lawsuit Against RxSight, Inc. and Announces Opportunity for Investors with Substantial Losses to Lead Class Action Lawsuit - Business Wire
DEADLINE NEXT WEEK: Berger Montague Advises RxSight, Inc. (NASDAQ: RXST) Investors to Contact the Firm Before September 22, 2025 | Dow Theory Letters - FinancialContent
Investors SueWallSt as RxSight, Inc. Faces Securities Fraud Allegations - Nasdaq
Risk Recap: Can RxSight Inc sustain its profitabilityJuly 2025 Momentum & Risk Managed Investment Signals - khodrobank.com
RXST LEGAL NEWS: RxSight, Inc. Faces Securities Class - GlobeNewswire
Class Action Filed Against RxSight, Inc. (RXST) Seeking Recovery for InvestorsContact Levi & Korsinsky - FinancialContent
Investigation announced for Long-Term Investors in RxSight, Inc. (NASDAQ: RXST) over potential Wrongdoing - openPR.com
Rxsight Inc Stock (RXST) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.80%
1.23%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):